Abstracts
Important dates
Opening date for submission of abstracts: 01 March 2025
Closing date for submission of abstracts: 30 June 2025
01 August 2025
This year, we adopt the theme “Bridging the Gap,” reflecting our commitment to connecting research innovations with clinical practice and fostering meaningful partnerships between all stakeholders in haematological care.
Our objective for HaemOnc 2025 is to bridge critical gaps between innovative developments and the realities of our local context.
Please find important information below regarding guidelines for abstract submissions.
Abstract Submission Topics
The scientific programme will strive to address the following themes in the plenary sessions, parallel sessions, poster sessions, specialist symposia, workshops, and sessions with commercial appeal:
- Clinical Haematology research – benign and malignant
- Laboratory Haematology research
- Patient Blood Management
- Transfusion Medicine
- Basic science research
- Case presentation
- Presentation by a non-profit organisation
Abstract Submission Guidelines
- Abstract submissions must be submitted online. Emailed submissions will not be accepted.
- Abstracts can be submitted for oral or poster presentation.
- Abstract submissions should be original, topical, and current.
- The title of your abstract should not exceed 50 words.
- The body text of your abstract should not exceed 350 words.
Guidelines for Original Research Abstracts
All original research submissions should preferably not have been previously accepted for publication in a journal, presented at another conference.
The abstract should contain the following sections: Introduction, Methodology, Results, Discussion and Conclusions.
The introduction should give a brief background of the research topic, stating the problem and leading to the aim of the specific research.
A brief description of the methodology and techniques used in the research should be given.
The results and discussion section should give a concise presentation of the results obtained and highlight any trends or points of interest. Statements such as “results will be presented” or “will be discussed” are not acceptable and such abstracts will be rejected.
A brief explanation of the significance and implications of the work reported should conclude the abstract.
Acceptance/Rejection of Abstracts
The scientific programme committee will review all submitted abstracts and reserves the right to accept or reject any abstracts. Selected abstracts will be presented as oral or poster presentations.
All authors will be kept informed, in writing, of the details concerning the exact time and date of their presentation. Poster presenters will be notified of the poster size and guidelines in writing as well.